Basic Information
| RNALocate ID: | RLID:11000637 |
| RNA Symbol: | hsa-let-7e-5p |
| Localization: | Extracellular vesicle |
RNA Information
| RNA Name: | hsa-let-7e |
| RNA ID: | miRBase:MIMAT0000066 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22849433 |
| Tissue/Cell Line: | HEK-293T cells |
| Method: | Next-generation RNA sequencing |
| Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001230 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001231 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001232 | Cytoplasm | HeLa cells | 22058130 |
| RLID:01001233 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001234 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001235 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001236 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001237 | Nucleolus | Myoblasts | 19628621 |
| RLID:01001238 | Nucleolus | Breast adenocarcinoma cells (MCF-7) | 24918059 |
| RLID:01001239 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001240 | Nucleus | HeLa cells | 22058130 |
| RLID:11000626 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000627 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
| RLID:11000628 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
| RLID:11000629 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000630 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11000631 | Exosome | Breast milk | 22211110 |
| RLID:11000632 | Exosome | Epidermal melanocytes (HEMa-LP) | 23056502 |
| RLID:11000633 | Exosome | Brain tissue | 23382797 |
| RLID:11000634 | Exosome | Plasma | 23663360 |
| RLID:11000635 | Exosome | K562 cells | 24460325 |
| RLID:11000636 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11000638 | Microvesicle | Plasma | 23077538 |
| RLID:11000639 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000005 | Exosome | Endothelial cells|Epithelial cells|Mast cells|Seminal fluid | |
| RLID-D:11000265 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-let-7e-5p | Diffuse large b cell lymphoma | MNDR-E-MI-01439 |
| MNDR | hsa-let-7e-5p | Splenic marginal zone lymphoma | MNDR-E-MI-01440 |
| MNDR | hsa-let-7e-5p | Colorectal adenoma | MNDR-E-MI-01441 |
| MNDR | hsa-let-7e-5p | Oral squamous cell carcinoma | MNDR-E-MI-01442 |
| MNDR | hsa-let-7e-5p | Lymphoma non-hodgkin | MNDR-E-MI-01443 |
| MNDR | hsa-let-7e-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-01444 |
| MNDR | hsa-let-7e-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-01445 |
| MNDR | hsa-let-7e-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-01446 |
| MNDR | hsa-let-7e-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-01447 |
| MNDR | hsa-let-7e-5p | Breast cancer luminal | MNDR-E-MI-01448 |
| MNDR | hsa-let-7e-5p | Prostate cancer | MNDR-E-MI-01449 |
| MNDR | hsa-let-7e-5p | Gastric cancer | MNDR-E-MI-01450 |
| MNDR | hsa-let-7e-5p | Gastric lymphoma | MNDR-E-MI-01451 |
| MNDR | hsa-let-7e-5p | Alzheimer disease | MNDR-E-MI-01452 |
| MNDR | hsa-let-7e-5p | Dysautonomia familial | MNDR-E-MI-01453 |
| MNDR | hsa-let-7e-5p | Head and neck cancer | MNDR-E-MI-01454 |
| MNDR | hsa-let-7e-5p | Leukemia | MNDR-E-MI-01455 |
| MNDR | hsa-let-7e-5p | Cardiovascular disease | MNDR-E-MI-01456 |
| MNDR | hsa-let-7e-5p | Lung cancer | MNDR-E-MI-01457 |
| MNDR | hsa-let-7e-5p | Metabolic syndrome x | MNDR-E-MI-01458 |
| MNDR | hsa-let-7e-5p | Parkinson disease | MNDR-E-MI-01459 |
| MNDR | hsa-let-7e-5p | Colonic adenomas | MNDR-E-MI-01460 |
| MNDR | hsa-let-7e-5p | Basal-like breast cancer | MNDR-E-MI-01461 |
| MNDR | hsa-let-7e-5p | Thyroid cancer | MNDR-E-MI-01462 |
| MNDR | hsa-let-7e-5p | Pancreatic cancer | MNDR-E-MI-01463 |
| MNDR | hsa-let-7e-5p | Melanoma | MNDR-E-MI-01464 |
| MNDR | hsa-let-7e-5p | Nephroblastoma | MNDR-E-MI-01465 |
| MNDR | hsa-let-7e-5p | Colon cancer | MNDR-E-MI-01466 |
| MNDR | hsa-let-7e-5p | Ischemic attack transient | MNDR-E-MI-01467 |
| MNDR | hsa-let-7e-5p | Colon adenocarcinoma | MNDR-E-MI-01468 |
| MNDR | hsa-let-7e-5p | Familial ovarian cancer | MNDR-E-MI-01469 |
| MNDR | hsa-let-7e-5p | Prostate adenocarcinoma | MNDR-E-MI-01470 |
| MNDR | hsa-let-7e-5p | Carcinoma ductal breast | MNDR-E-MI-01471 |
| MNDR | hsa-let-7e-5p | Glioblastoma | MNDR-E-MI-01472 |
| MNDR | hsa-let-7e-5p | Malignant glioma | MNDR-E-MI-01473 |
| MNDR | hsa-let-7e-5p | Chordoma | MNDR-E-MI-01474 |
| MNDR | hsa-let-7e-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-01475 |
| MNDR | hsa-let-7e-5p | Temporal lobe epilepsy | MNDR-E-MI-01476 |
| MNDR | hsa-let-7e-5p | Osteosarcoma | MNDR-E-MI-01477 |
| MNDR | hsa-let-7e-5p | Liver cancer | MNDR-E-MI-01478 |
| MNDR | hsa-let-7e-5p | Uterine cancer | MNDR-E-MI-01479 |
| MNDR | hsa-let-7e-5p | Cervical adenocarcinoma | MNDR-E-MI-01480 |
| MNDR | hsa-let-7e-5p | Gastric adenocarcinoma | MNDR-E-MI-01481 |
| MNDR | hsa-let-7e-5p | Lung squamous cell carcinoma | MNDR-E-MI-01482 |
| MNDR | hsa-let-7e-5p | Lung adenocarcinoma | MNDR-E-MI-01483 |
| MNDR | hsa-let-7e-5p | Adrenocortical cancer | MNDR-E-MI-01484 |
| MNDR | hsa-let-7e-5p | Thyroid carcinoma | MNDR-E-MI-01485 |
| MNDR | hsa-let-7e-5p | Pancreatic adenocarcinoma | MNDR-E-MI-01486 |
| MNDR | hsa-let-7e-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-01487 |
| MNDR | hsa-let-7e-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-01488 |
| MNDR | hsa-let-7e-5p | Renal clear cell carcinoma | MNDR-E-MI-01489 |
| MNDR | hsa-let-7e-5p | Biliary tract cancer | MNDR-E-MI-01490 |
| MNDR | hsa-let-7e-5p | Cholangiocarcinoma | MNDR-E-MI-01491 |
| MNDR | hsa-let-7e-5p | Esophageal cancer | MNDR-E-MI-01492 |
| MNDR | hsa-let-7e-5p | Liver cirrhosis | MNDR-E-MI-01493 |
| MNDR | hsa-let-7e-5p | Synovial sarcoma | MNDR-E-MI-01494 |
| MNDR | hsa-let-7e-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-01495 |
| MNDR | hsa-let-7e-5p | Adenoma | MNDR-E-MI-01496 |
| MNDR | hsa-let-7e-5p | Breast invasive carcinoma | MNDR-E-MI-01497 |
| MNDR | hsa-let-7e-5p | Early hepatocellular carcinoma | MNDR-E-MI-01498 |
| MNDR | hsa-let-7e-5p | Familiar ovarian carcinoma | MNDR-E-MI-01499 |
| MNDR | hsa-let-7e-5p | B-cell lymphoma | MNDR-E-MI-01500 |
| MNDR | hsa-let-7e-5p | Rheumatoid arthritis | MNDR-E-MI-01501 |
| MNDR | hsa-let-7e-5p | T-cell leukemia | MNDR-E-MI-01502 |
| MNDR | hsa-let-7e-5p | Retinoblastoma | MNDR-E-MI-01503 |
| MNDR | hsa-let-7e-5p | Neuroblastoma | MNDR-E-MI-01504 |
| MNDR | hsa-let-7e-5p | Hodgkin lymphoma | MNDR-E-MI-01505 |
| MNDR | hsa-let-7e-5p | Burkitt lymphoma | MNDR-E-MI-01506 |
| MNDR | hsa-let-7e-5p | Tonsil cancer | MNDR-E-MI-01507 |
| MNDR | hsa-let-7e-5p | Neuromyelitis optica | MNDR-E-MI-01508 |
| MNDR | hsa-let-7e-5p | Acute myelogenous leukemia | MNDR-E-MI-01509 |
| MNDR | hsa-let-7e-5p | Colorectal cancer | MNDR-E-MI-01510 |
| MNDR | hsa-let-7e-5p | Nasopharynx carcinoma | MNDR-E-MI-01511 |
| MNDR | hsa-let-7e-5p | Multiple myeloma | MNDR-E-MI-01512 |
| MNDR | hsa-let-7e-5p | Nasopharyngeal cancer | MNDR-E-MI-01513 |
| MNDR | hsa-let-7e-5p | Prostatic neoplasms | MNDR-E-MI-01514 |
| MNDR | hsa-let-7e-5p | Epstein-barr virus infections | MNDR-E-MI-01515 |
| MNDR | hsa-let-7e-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-01516 |
| MNDR | hsa-let-7e-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-01517 |
| MNDR | hsa-let-7e-5p | Stroke | MNDR-E-MI-01518 |
| MNDR | hsa-let-7e-5p | Stroke lacunar | MNDR-E-MI-01519 |
| MNDR | hsa-let-7e-5p | Duke C | MNDR-E-MI-01520 |
| MNDR | hsa-let-7e-5p | Low grade dysplastic nodule | MNDR-E-MI-01521 |
| MNDR | hsa-let-7e-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-01522 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR1B | Homo sapiens | RR00038913 |
TOP